It doesn't help, and TBH it's painful to watch, so I will fill in a few gaps for you. I haven't done a deep dive into the quarterly, I wasn't on the line, and haven't caught the replay, and I am only going to end Q1FY25, but here goes...
Revenue Q4FY24 $20M (full earnings from Alinta GSA kick in, no lift in production)
Revenue Q1FY25 $20M (as above)
less projected exploration 30/9/24
SE $0M
W7 drill $10M
ED1 drill $10M (50%)
TEG drill $5M (25%)
WE FID? $10M (Q4CY24?)
less opex
Walyering $9M
Debt reduction $6M
Corporate $7M
total expenses for the next 6 months = $57M
net movement = -$17M
some long lead items may have been paid for pre 31/3/24 but let's leave them in as we can't verify this
How does that look?
- Forums
- ASX - By Stock
- Ann: 3Q FY24 Quarterly Report & Appendix 5B
It doesn't help, and TBH it's painful to watch, so I will fill...
-
-
- There are more pages in this discussion • 235 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add STX (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $673.3M |
Open | High | Low | Value | Volume |
23.5¢ | 24.0¢ | 23.0¢ | $2.088M | 8.896M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 595306 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 3222624 | 40 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 595306 | 0.235 |
15 | 1828836 | 0.230 |
9 | 802812 | 0.225 |
14 | 1592602 | 0.220 |
15 | 1871772 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 3222624 | 40 |
0.245 | 1634060 | 27 |
0.250 | 2432716 | 30 |
0.255 | 2676153 | 8 |
0.260 | 5036143 | 21 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
STX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online